Catalyst Wire Dossier Catalyst Wire Dossier

SclerosTin antibody

· Amgen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SclerosTin antibody, covering 2019-05-02 to 2019-05-02. Get the full timeline:

Most recent: Clinical Trial Update: Study To Assess FRacTure Healing With SclerosTin Antibody - Hip [Phase 2]

See pricing